Report #2874970

Received Nov 25, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 0.3 yrs
State: KY
Recovered: Recovered
Vaccinated: Jan 2, 2025
Onset: Jan 7, 2025
Days to onset: 5
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
DTPPVHBHPB	DTAP+IPV+HIB+HEPB (VAXELIS)	MSP VACCINE COMPANY	UNK	U7899AA	LL

Symptoms (3)

Injection site reactionInjection site vesiclesWound secretion

Symptom narrative

Blisters began to develop where VAXELIS and BEYFORTUS administered/ The blisters developed with open wounds, described as "oozing on 11JAN2025; This non-serious spontaneous safety report with Global PV Identification number 2025SA251017 (Inquiry number#02629119) was received by partner on 20-AUG-2025 and forwarded to Regulatory Agency on 22-AUG-2025 from a Health Professional. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "Blisters began to develop where VAXELIS and BEYFORTUS were administered on 07JAN2025. The blisters developed with open wounds, described as "oozing on 11JAN2025". Further Information is expected.

Current illness

Prophylaxis

Other medications

PNEUMOCOCCAL VACCINE CONJ 20V (CRM197); BEYFORTUS [NIRSEVIMAB]